Millennium Management
HRTX icon

Millennium Management’s Heron Therapeutics HRTX Stock Holding History

Millennium Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.11M Buy
7,630,527
+460,619
+6% +$534K ﹤0.01% 2719
2025
Q4 		$9.32M Buy
7,169,908
+6,921,405
+2,785% +$8.55M 0.01% 2337
2025
Q3 		$313K Sell
248,503
-243,834
-50% -$387K ﹤0.01% 5319
2025
Q2 		$1.02M Sell
492,337
-902,948
-65% -$1.84M ﹤0.01% 4391
2025
Q1 		$3.07M Buy
1,395,285
+1,179,754
+547% +$2.29M ﹤0.01% 3366
2024
Q4 		$330K Sell
215,531
-718,857
-77% -$1.17M ﹤0.01% 5019
2024
Q3 		$1.86M Sell
934,388
-500,239
-35% -$1.19M ﹤0.01% 3764
2024
Q2 		$5.02M Sell
1,434,627
-1,732,659
-55% -$5.32M ﹤0.01% 2725
2024
Q1 		$8.77M Buy
3,167,286
+1,930,129
+156% +$4.85M 0.01% 2315
2023
Q4 		$2.1M Buy
1,237,157
+1,160,465
+1,513% +$1.28M ﹤0.01% 3562
2023
Q3 		$79K Sell
76,692
-17,102
-18% -$24.3K ﹤0.01% 5391
2023
Q2 		$109K Sell
93,794
-471,994
-83% -$842K ﹤0.01% 5312
2023
Q1 		$854K Sell
565,788
-2,940,566
-84% -$7.36M ﹤0.01% 4231
2022
Q4 		$8.77M Buy
3,506,354
+1,825,388
+109% +$5.88M 0.01% 2278
2022
Q3 		$7.09M Buy
1,680,966
+1,449,328
+626% +$5.67M 0.01% 2542
2022
Q2 		$646K Sell
231,638
-971,100
-81% -$3.9M ﹤0.01% 4750
2022
Q1 		$6.88M Buy
1,202,738
+197,940
+20% +$1.45M 0.01% 2596
2021
Q4 		$9.17M Buy
+1,004,798
New +$10.3M 0.01% 2230
2021
Q3 		– Sell
-327,721
Closed -$5.09M – 7014
2021
Q2 		$5.09M Sell
327,721
-712,125
-68% -$11.3M 0.01% 2735
2021
Q1 		$16.9M Buy
1,039,846
+839,815
+420% +$15M 0.02% 1237
2020
Q4 		$4.23M Sell
200,031
-4,207
-2% -$73.1K 0.01% 2598
2020
Q3 		$3.03K Buy
+204,238
New +$3.19M 0.01% 2271
2020
Q2 		– Sell
-507,854
Closed -$5.96M – 4349
2020
Q1 		$5.96M Sell
507,854
-199,690
-28% -$3.75M 0.02% 1204
2019
Q4 		$16.6M Buy
707,544
+140,613
+25% +$3.11M 0.03% 968
2019
Q3 		$10.5M Buy
566,931
+217,302
+62% +$4M 0.02% 1255
2019
Q2 		$6.5M Buy
349,629
+284,979
+441% +$5.69M 0.01% 1571
2019
Q1 		$1.58M Buy
+64,650
New +$1.69M ﹤0.01% 2566
2018
Q4 		– Sell
-41,535
Closed -$1.31M – 3928
2018
Q3 		$1.31M Sell
41,535
-137,829
-77% -$5.13M ﹤0.01% 2717
2018
Q2 		$6.97M Buy
+179,364
New +$5.71M 0.01% 1569
2018
Q1 		– Sell
-315,173
Closed -$5.71M – 3830
2017
Q4 		$5.71M Sell
315,173
-54,701
-15% -$892K 0.01% 1679
2017
Q3 		$5.97M Buy
369,874
+201,097
+119% +$3.15M 0.01% 1570
2017
Q2 		$2.34M Buy
+168,777
New +$2.44M ﹤0.01% 1986
2017
Q1 		– Sell
-257,062
Closed -$3.37M – 3644
2016
Q4 		$3.37M Buy
+257,062
New +$4.03M 0.01% 1597
2016
Q2 		– Hold
0
– – – 3341
2016
Q1 		– Hold
0
– – – 3446
2015
Q3 		– Sell
-760,146
Closed -$23.7M – 3579
2015
Q2 		$23.7M Buy
760,146
+83,994
+12% +$1.58M 0.05% 543
2015
Q1 		$9.84M Buy
676,152
+427,795
+172% +$4.82M 0.02% 1021
2014
Q4 		$2.5M Buy
248,357
+47,888
+24% +$391K 0.01% 1837
2014
Q3 		$1.67M Sell
200,469
-12,537
-6% -$117K ﹤0.01% 1989
2014
Q2 		$2.62M Buy
213,006
+40,309
+23% +$482K 0.01% 1592
2014
Q1 		$2.4M Buy
+172,697
New +$2.31M 0.01% 1647

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
CPC
Congress Park Capital Saratoga Springs, New York $370M AUM 26.01% 1-Year Est. Return